Jianqing Lin, M.D., Thomas Jefferson University Hospital (IMAGE)

Thomas Jefferson University

Jianqing Lin, M.D., Thomas Jefferson University Hospital

Caption

The Kimmel Cancer Center at Jefferson will begin a multimodality Phase I trial with the next "major advance in chemotherapy for advanced prostate cancer."

Credit

TJUH

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.